Gao YM - Search Results

1

Wang B, Li ZL, Zhang YL, Wen Y, Gao YM, Liu BC. Wang B, et al. Among authors: gao ym. EBioMedicine. 2022 Mar;77:103942. doi: 10.1016/j.ebiom.2022.103942. Epub 2022 Mar 13. EBioMedicine. 2022. PMID: 35290825 Free PMC article. Review.

2

Elevated Urinary Neutrophil Gelatinase-Associated Lipocalin Is a Biomarker for Lupus Nephritis: A Systematic Review and Meta-Analysis.

Gao Y, Wang B, Cao J, Feng S, Liu B. Gao Y, et al. Biomed Res Int. 2020 Jun 30;2020:2768326. doi: 10.1155/2020/2768326. eCollection 2020. Biomed Res Int. 2020. PMID: 32685458 Free PMC article.

3

Identification of Lumican and Fibromodulin as Hub Genes Associated with Accumulation of Extracellular Matrix in Diabetic Nephropathy.

Feng S, Gao Y, Yin D, Lv L, Wen Y, Li Z, Wang B, Wu M, Liu B. Feng S, et al. Kidney Blood Press Res. 2021;46(3):275-285. doi: 10.1159/000514013. Epub 2021 Apr 22. Kidney Blood Press Res. 2021. PMID: 33887734 Free article.

4

Kim-1 Targeted Extracellular Vesicles: A New Therapeutic Platform for RNAi to Treat AKI.

Tang TT, Wang B, Li ZL, Wen Y, Feng ST, Wu M, Liu D, Cao JY, Yin Q, Yin D, Fu YQ, Gao YM, Ding ZY, Qian JY, Wu QL, Lv LL, Liu BC. Tang TT, et al. Among authors: gao ym. J Am Soc Nephrol. 2021 Oct;32(10):2467-2483. doi: 10.1681/ASN.2020111561. Epub 2021 Jun 14. J Am Soc Nephrol. 2021. PMID: 34127536 Free PMC article.

5

Urinary sediment CCL5 messenger RNA as a potential prognostic biomarker of diabetic nephropathy.

Feng ST, Yang Y, Yang JF, Gao YM, Cao JY, Li ZL, Tang TT, Lv LL, Wang B, Wen Y, Sun L, Xing GL, Liu BC. Feng ST, et al. Among authors: gao ym. Clin Kidney J. 2021 Sep 28;15(3):534-544. doi: 10.1093/ckj/sfab186. eCollection 2022 Mar. Clin Kidney J. 2021. PMID: 35211307 Free PMC article.

6

Development and External Validation of a Nomogram and a Risk Table for Prediction of Type 2 Diabetic Kidney Disease Progression Based on a Retrospective Cohort Study in China.

Gao YM, Feng ST, Yang Y, Li ZL, Wen Y, Wang B, Lv LL, Xing GL, Liu BC. Gao YM, et al. Diabetes Metab Syndr Obes. 2022 Mar 14;15:799-811. doi: 10.2147/DMSO.S352154. eCollection 2022. Diabetes Metab Syndr Obes. 2022. PMID: 35313680 Free PMC article.

7

Cardiorenal protection of SGLT2 inhibitors-Perspectives from metabolic reprogramming.

Gao YM, Feng ST, Wen Y, Tang TT, Wang B, Liu BC. Gao YM, et al. EBioMedicine. 2022 Sep;83:104215. doi: 10.1016/j.ebiom.2022.104215. Epub 2022 Aug 13. EBioMedicine. 2022. PMID: 35973390 Free PMC article. Review.

8

Association between triglyceride-glucose index and risk of end-stage renal disease in patients with type 2 diabetes mellitus and chronic kidney disease.

Gao YM, Chen WJ, Deng ZL, Shang Z, Wang Y. Gao YM, et al. Front Endocrinol (Lausanne). 2023 Apr 20;14:1150980. doi: 10.3389/fendo.2023.1150980. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37152938 Free PMC article.

9

Clinical predictive factors and prediction models for end-stage renal disease in Chinese patients with type 2 diabetes mellitus.

Gao Y, Shang Z, Nie S, Feng S, Wang B, Li Z, Wu M, Wen Y, Xu H, Weng J, Chen C, Liu H, Yang Q, Li H, Kong Y, Li G, Wan Q, Zha Y, Hu Y, Xu G, Shi Y, Zhou Y, Su G, Tang Y, Gong M, Fan HF, Liu B. Gao Y, et al. Clin Transl Med. 2023 Jul;13(7):e1323. doi: 10.1002/ctm2.1323. Clin Transl Med. 2023. PMID: 37386765 Free PMC article. No abstract available.

10

[Two cases of cytopenia associated with multiple malformations].

Chang LX, Zhang L, Gao YM, Zhu XF. Chang LX, et al. Among authors: gao ym. Zhongguo Dang Dai Er Ke Za Zhi. 2024 Apr 15;26(4):410-413. doi: 10.7499/j.issn.1008-8830.2311058. Zhongguo Dang Dai Er Ke Za Zhi. 2024. PMID: 38660906 Free PMC article. Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

195 results

Search Page